| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |